Breath and plasma metabolomics to assess inflammation in acute stroke

Ahmed, Waqar and White, Iain R. and Wilkinson, Maxim and Johnson, Craig F. and Rattray, Nicholas and Kishore, Amit K. and Goodacre, Royston and Smith, Craig J. and Fowler, Stephen J. (2021) Breath and plasma metabolomics to assess inflammation in acute stroke. Scientific Reports, 11 (1). 21949. ISSN 2045-2322 (https://doi.org/10.1038/s41598-021-01268-5)

[thumbnail of Ahmed-etal-SR-2021-Breath-and-plasma-metabolomics-to-assess-inflammation-in-acute-stroke]
Preview
 Text. Filename: Ahmed_etal_SR_2021_Breath_and_plasma_metabolomics_to_assess_inflammation_in_acute_stroke.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (2MB)| Preview

Abstract

Inflammation is strongly implicated in both injury and repair processes occurring after stroke. In this exploratory study we assessed the feasibility of repeated sampling of exhaled volatile organic compounds and performed an untargeted metabolomic analysis of plasma collected at multiple time periods after stroke. Metabolic profiles were compared with the time course of the inflammatory markers C-reactive protein (CRP) and interleukin-6 (IL-6). Serial breath sampling was well-tolerated by all patients and the measurement appears feasible in this group. We found that exhaled decanal tracks CRP and IL-6 levels post-stroke and correlates with several metabolic pathways associated with a post-stroke inflammatory response. This suggests that measurement of breath and blood metabolites could facilitate development of novel therapeutic and diagnostic strategies. Results are discussed in relation to the utility of breath analysis in stroke care, such as in monitoring recovery and complications including stroke associated infection.

CORE (COnnecting REpositories)